Company / Revenue per Share
GT Biopharma, Inc. Revenue per Share History
FY2011-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
-
FY2020
5-year range
$0.00 / $0.03
FY2016-FY2020
Trend
-
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.01 to $0.00 over the past 4 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak revenue per share was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $0.00 | - |
| FY2017 | $0.00 | -100.0% |
| FY2016 | $0.01 | -56.4% |
| FY2015 | $0.03 | +3913.8% |
| FY2014 | $0.00 | -6.0% |
| FY2013 | $0.00 | +607.7% |
| FY2012 | $0.00 | +31.3% |
| FY2011 | $0.00 | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026